Cargando…

High Expression of PHGDH Predicts Poor Prognosis in Non–Small Cell Lung Cancer()

Tumors have exceptionally high demands for energy and anabolism because of their rapid growth. The de novo serine synthesis pathway initiated by phosphoglycerate dehydrogenase (PHGDH) has been recognized as a hallmark of metabolic adaption in carcinogenesis. The oncogenic role and prognostic value o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Jinhong, Ma, Jianqun, Wang, Xudong, Ma, Tianjiao, Zhang, Shu, Wang, Wei, Zhou, Xiaoyu, Shi, Jiahai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2016
Materias:	Original article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5143353/ https://www.ncbi.nlm.nih.gov/pubmed/27916294 http://dx.doi.org/10.1016/j.tranon.2016.08.003

Ejemplares similares

Development of immune gene pair-based signature predictive of prognosis and immunotherapy in esophageal cancer
por: Cao, Kui, et al.
Publicado: (2021)

Comprehensive analysis of PHGDH for predicting prognosis and immunotherapy response in patients with endometrial carcinoma
por: Zhang, He, et al.
Publicado: (2023)

High TMPRSS11D protein expression predicts poor overall survival in non-small cell lung cancer
por: Cao, Xiang, et al.
Publicado: (2017)

Increased Expression of PHGDH and Prognostic Significance in Colorectal Cancer
por: Jia, Xiao-qin, et al.
Publicado: (2016)

Development of a cuproptosis-related signature for prognosis prediction in lung adenocarcinoma based on WGCNA
por: Ling, Xiaodong, et al.
Publicado: (2023)

Low expression of IL6R predicts poor prognosis for lung adenocarcinoma
por: Sun, Gaofeng, et al.
Publicado: (2021)

Comprehensive Analysis of the Immune Implication of ACK1 Gene in Non-small Cell Lung Cancer
por: Zhu, Jinhong, et al.
Publicado: (2020)

Dimerization of PHGDH via the catalytic unit is essential for its enzymatic function
por: Xu, Hanyu, et al.
Publicado: (2021)

LncRNA HAR1A Suppresses the Development of Non-Small Cell Lung Cancer by Inactivating the STAT3 Pathway
por: Ma, Jianqun, et al.
Publicado: (2022)

Identification of downstream signaling cascades of ACK1 and prognostic classifiers in non-small cell lung cancer
por: Zhu, Jinhong, et al.
Publicado: (2021)

Overexpression of periostin predicts poor prognosis in non-small cell lung cancer
por: HONG, LING-ZHI, et al.
Publicado: (2013)

Loss of IL-34 Expression Indicates Poor Prognosis in Patients With Lung Adenocarcinoma
por: Wang, Zhendong, et al.
Publicado: (2021)

Prognostic implications of autophagy-associated gene signatures in non-small cell lung cancer
por: Liu, Yang, et al.
Publicado: (2019)

Validating and enabling phosphoglycerate dehydrogenase (PHGDH) as a target for fragment-based drug discovery in PHGDH-amplified breast cancer
por: Unterlass, Judith E., et al.
Publicado: (2016)

High expression of interleukin-enhancer binding factor 3 predicts poor prognosis in patients with lung adenocarcinoma
por: Xu, Zhangyan, et al.
Publicado: (2020)

Nociceptin Receptor Is Overexpressed in Non-small Cell Lung Cancer and Predicts Poor Prognosis
por: Wang, Kaiyuan, et al.
Publicado: (2019)

FoxQ1 Overexpression Influences Poor Prognosis in Non-Small Cell Lung Cancer, Associates with the Phenomenon of EMT
por: Feng, Jian, et al.
Publicado: (2012)

Increased PHGDH expression promotes aberrant melanin accumulation
por: Mattaini, Katherine R., et al.
Publicado: (2019)

PHGDH as a mechanism for resistance in metabolically-driven cancers
por: Rathore, Richa, et al.
Publicado: (2020)

Multi-omics Analysis of the Role of PHGDH in Colon Cancer
por: Dai, Zhihui, et al.
Publicado: (2023)

High expression of Stabilin-2 predicts poor prognosis in non-small-cell lung cancer
por: Yong, Juanjuan, et al.
Publicado: (2021)

Increased Expression of TAP Is Predictive of Poor Prognosis in Patients with Non-Small Cell Lung Cancer
por: Cheng, Yuanjun, et al.
Publicado: (2020)

Upregulation of phosphoserine phosphatase contributes to tumor progression and predicts poor prognosis in non‐small cell lung cancer patients
por: Liao, Li, et al.
Publicado: (2019)

ZEB1 Transcriptionally Activates PHGDH to Facilitate Carcinogenesis and Progression of HCC
por: Wang, Huihui, et al.
Publicado: (2023)

UBE2T Contributes to the Prognosis of Esophageal Squamous Cell Carcinoma
por: Wang, Xiaoyuan, et al.
Publicado: (2021)

Expression of Cripto‐1 predicts poor prognosis in stage I non‐small cell lung cancer
por: Xu, Chunhua, et al.
Publicado: (2020)

A Low Advanced Lung Cancer Inflammation Index Predicts a Poor Prognosis in Patients With Metastatic Non–Small Cell Lung Cancer
por: Lu, Ping, et al.
Publicado: (2022)

AKR7A3 modulates the metastasis of pancreatic ductal adenocarcinoma through regulating PHGDH‐suppressed autophagy
por: Hua, Lei, et al.
Publicado: (2023)

Enhanced expression of FGF19 predicts poor prognosis in patients with non-small cell lung cancer
por: Chen, Jia, et al.
Publicado: (2021)

Elevated expression of FABP3 and FABP4 cooperatively correlates with poor prognosis in non-small cell lung cancer (NSCLC)
por: Tang, Zhiyuan, et al.
Publicado: (2016)

PHGDH supports liver ceramide synthesis and sustains lipid homeostasis
por: Kang, Yun Pyo, et al.
Publicado: (2020)

A Low Albumin-to-Globulin Ratio Predicts a Poor Prognosis in Patients With Metastatic Non-small-cell Lung Cancer
por: Lu, Ping, et al.
Publicado: (2021)

LINC00669 promotes lung adenocarcinoma growth by stimulating the Wnt/β‐catenin signaling pathway
por: Zhu, Jinhong, et al.
Publicado: (2023)

Labyrinthin Expression Is Associated with Poor Prognosis in Patients with Non-Small-Cell Lung Cancer
por: Ma, Weijie, et al.
Publicado: (2023)

Elevated Nuclear PHGDH Synergistically Functions with cMyc to Reshape the Immune Microenvironment of Liver Cancer
por: Zhu, Hongwen, et al.
Publicado: (2023)

Contribution of upregulated dipeptidyl peptidase 9 (DPP9) in promoting tumoregenicity, metastasis and the prediction of poor prognosis in non‐small cell lung cancer (NSCLC)
por: Tang, Zhiyuan, et al.
Publicado: (2017)

Cytoplasmic Kaiso is associated with poor prognosis in non-small cell lung cancer
por: Dai, Shun-Dong, et al.
Publicado: (2009)

Identification of a novel PHGDH covalent inhibitor by chemical proteomics and phenotypic profiling
por: Chen, Chen, et al.
Publicado: (2022)

Overexpressed p-S6 associates with lymph node metastasis and predicts poor prognosis in non-small cell lung cancer
por: Tang, Yaoxiang, et al.
Publicado: (2022)

MARCH8 is associated with poor prognosis in non-small cell lung cancers patients
por: Fan, Jiye, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_dbqq5ctm4jq8a2qp0em75l5600